I89.0

✓ Billable

Lymphedema, not elsewhere classified

Diseases of the circulatory system (I00-I99)

Check This Code

Also Known As

Elephantiasis (nonfilarial) NOSLymphangiectasisObliteration, lymphatic vesselPraecox lymphedemaSecondary lymphedema

❌ Excludes1

direct

These codes are mutually exclusive. Never code them together.

  • postmastectomy lymphedema (I97.2)

❌ Excludes1

inherited

Rules inherited from parent codes in the hierarchy.

  • chylocele, tunica vaginalis (nonfilarial) NOS (N50.89)
  • enlarged lymph nodes NOS (R59.-)
  • filarial chylocele (B74.-)
  • hereditary lymphedema (Q82.0)

Clinical Description

ICD-10-CM code I89.0 represents lymphedema, not elsewhere classified. This code falls under the Diseases of the circulatory system (I00-I99) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.

This is a 5-character code at the 4th level of specificity. This is the most specific code available in this subcategory. Coders should note that I89.0 has 5 Excludes1 restriction(s) — codes that cannot be reported together on the same claim.

Frequently Asked Questions

What is ICD-10 code I89.0?

ICD-10-CM code I89.0 is "Lymphedema, not elsewhere classified". It belongs to the category: Diseases of the circulatory system (I00-I99).

Is I89.0 a billable ICD-10 code?

Yes, I89.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What codes are excluded with I89.0?

I89.0 has 5 Excludes1 rule(s). These codes are mutually exclusive and cannot be coded together on the same claim.

🧪 Validate Combinations

Add I89.0 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeI89.0
BillableYes
ParentI89
CategoryDiseases of the circulatory system (I00-I99)
Excludes15 rule(s)
Excludes20 note(s)

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)